UNIJECT(R) AS A DELIVERY SYSTEM FOR THE ONCE-A-MONTH INJECTABLE CONTRACEPTIVE CYCLOFEM(R) IN BRAZIL

This study assessed the administration of Cyclofem(R) using prefilled Uniject(R) devices. A total of 480 injections were administered divide d equally between standard syringes and Uniject. The majority of women (82%) reported that they felt anxious prior to receiving the injectio n with Uniject. After injection, more than 80% expressed no anxiety ab out the appearance of uniject or about the technique of injection. A t otal of 96.3% of the participants reported slight to no pain with Unij ect. In comparison to the standard syringe, 5.6% expressed having had more pain with Uniject. Ninety percent of the service providers report ed that Uniject was easy to activate and inject and that it was reassu ring for users to know that the syringe and needle had never been used previously. Only two service providers demonstrated difficulties in a ctivating the device. No accidental punctures occurred during the mani pulation, and incomplete emptying of the Uniject was not observed. In conclusion, Uniject is a good device for the administration of the inj ectable contraceptive Cyclofem. It is likely to be appropriate for the delivery oi other injectable contraceptives after the necessary stabi lity tests have been performed.